SATEERA®, a Malaysian biotechnology pioneer in Smart Anti-Infective Innovation, has solidified its regional leadership with multiple recognitions for its patented natural anti-infective technology. The company was recently awarded BioNexus Status by the Malaysian Bioeconomy Development Corporation, together with a 10-year tax exemption, acknowledging its contribution to advancing sustainable, intelligent, and microbiome-conscious biotechnology from Malaysia to the global stage. This certification reflects SATEERA’s decade-long R&D journey and its commitment to reshaping conventional hygiene science by selectively inhibiting harmful bacteria while preserving beneficial microbes essential for human health.
Further affirming its regional prominence, ASIA Records recognized SATEERA as the First and Most Patented Natural Anti-Infective Formulation Preserving Beneficial Bacteria, supported by 14 international patents across Asia. This achievement underscores the company’s shift from traditional “kill-all” antibacterial approaches toward an intelligent, microbiome-safe model that protects the body’s natural defenses. Prof. Ir. Ts. Dr. Lai Chin Wei, Senior Scientific Advisor to SATEERA, described the innovation as a revolutionary breakthrough, marking the beginning of the Good Bacteria Era by promoting selective protection rather than indiscriminate destruction of microbes.
Dato’ Loh Shin Siong, Founder of SATEERA, emphasized that the company’s mission is to lead a fundamental shift in hygiene and biotechnology, prioritizing the preservation of beneficial bacteria while precisely targeting harmful microbes. The patented technology serves as a versatile platform, already applied in consumer solutions such as REDFORES, a next-generation intimate hygiene product that balances microbial health with effective antimicrobial support. REDFORES itself has received recognition from ASIA Records for its dual-action natural formulation, illustrating the scalability and adaptability of SATEERA’s core science across health and hygiene categories.
Independent validation from Universiti Teknologi Malaysia (UTM), University of Malaya (UM), and SGS Malaysia confirms that SATEERA’s innovation achieves strong antimicrobial performance while maintaining microbiome safety—a balance critical to long-term public health. Through its ESG-driven initiatives, including the upcycling of mangrove biomass into high-value bioactive compounds, SATEERA aligns scientific advancement with environmental sustainability, supporting Malaysia’s Bioeconomy Transformation Programme. With these multiple accolades, SATEERA continues to position Malaysia at the forefront of intelligent, microbiome-safe biotechnology, leading the Good Bacteria Era and shaping the future of health, hygiene, and wellness innovation.
